Heterozygous non-synonymous ROBO2 variants are unlikely to be sufficient to cause familial vesicoureteric reflux

Kidney International

Volumn 84, Issue 2, 2013, Pages 327-337

  Dobson, Mark G ^a,b   Darlow, John M ^a,b   Hunziker, Manuela ^b,c,d   Green, Andrew J ^a,d   Barton, David E ^a,d   Puri, Prem ^b,c,d  

^a National Centre for Medical Genetics   (Ireland)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^c ADELAIDE AND MEATH HOSPITAL   (Ireland)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

CAKUT; Mutation; ROBO2; Vesicoureteric reflux

Indexed keywords

DNA;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; EXON; FAMILIAL VESICOURETERAL REFLUX; FEMALE; GENE; GENE SEQUENCE; GENETIC CONSERVATION; HETEROZYGOSITY; HUMAN; IRELAND; IRISH; MAJOR CLINICAL STUDY; MALE; PATHOGENICITY; PRIORITY JOURNAL; PROMOTER REGION; ROBO2B GENE; VESICOURETERAL REFLUX;

CASE-CONTROL STUDIES; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HEREDITY; HETEROZYGOTE; HUMANS; IRELAND; MALE; PEDIGREE; PHENOTYPE; PROMOTER REGIONS, GENETIC; RECEPTORS, IMMUNOLOGIC; RISK FACTORS; VESICO-URETERAL REFLUX;

EID: 84881152945     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.100     Document Type: Article

References (27)

1. Gargollo PC, Diamond DA. Therapy insight: what nephrologists need to know about primary vesicoureteral reflux. Nat Clin Pract Nephrol 2007; 3: 551-563. (Pubitemid 47482717)
2. Mackie GG, Stephens FD. Duplex kidneys: a correlation of renal dysplasia with position of the ureteral orifice. J Urol 1975; 114: 274-280.
3. Thomas JC, DeMarco RT, Pope JCt. Molecular biology of ureteral bud and trigonal development. Curr Urol Rep 2005; 6: 146-151.
4. Ichikawa I, Kuwayama F, Pope JCt et al. Paradigm shift from classic anatomic theories to contemporary cell biological views of CAKUT. Kidney Int 2002; 61: 889-898. (Pubitemid 34175457)
5. Chen F. Genetic and developmental basis for urinary tract obstruction. Pediatric Nephrol (Berlin, Germany) 2009; 24: 1621-1632.
6. Murawski IJ, Gupta IR. Vesicoureteric reflux and renal malformations: a developmental problem. Clin Genet 2006; 69: 105-117. (Pubitemid 43372275)
7. Murer L, Benetti E, Artifoni L. Embryology and genetics of primary vesicoureteric reflux and associated renal dysplasia. Pediatric Nephrol (Berlin, Germany) 2007; 22: 788-797. (Pubitemid 46629612)
8. Schedl A. Renal abnormalities and their developmental origin. Nat Rev Genet 2007; 8: 791-802. (Pubitemid 47429212)
9. Song R, Yosypiv IV. Genetics of congenital anomalies of the kidney and urinary tract. Pediatric Nephrol (Berlin, Germany) 2011; 26: 353-364.
10. Uetani N, Bouchard M. Plumbing in the embryo: developmental defects of the urinary tracts. Clin Genet 2009; 75: 307-317.
11. Grieshammer U, Le M, Plump AS et al. SLIT2-mediated ROBO2 signaling restricts kidney induction to a single site. Dev Cell 2004; 6: 709-717. (Pubitemid 38579353)
12. Lu W, van Eerde AM, Fan X et al. Disruption of ROBO2 is associated with urinary tract anomalies and confers risk of vesicoureteral reflux. Am J Human Genet 2007; 80: 616-632. (Pubitemid 46564400)
13. Bertoli-Avella AM, Conte ML, Punzo F et al. ROBO2 gene variants are associated with familial vesicoureteral reflux. J Am Soc Nephrol 2008; 19: 825-831.
14. Zu S, Bartik Z, Zhao S et al. Mutations in the ROBO2 and SLIT2 genes are rare causes of familial vesico-ureteral reflux. Pediatric Nephrol 2009; 24: 1501-1508.
15. Yue Y, Grossmann B, Galetzka D et al. Isolation and differential expression of two isoforms of the ROBO2/Robo2 axon guidance receptor gene in humans and mice. Genomics 2006; 88: 772-778. (Pubitemid 44739196)
16. Harding SD, Armit C, Armstrong J et al. The GUDMAP database-an online resource for genitourinary research. Development 2011; 138: 2845-2853.
17. McMahon AP, Aronow BJ, Davidson DR et al. GUDMAP: the genitourinary developmental molecular anatomy project. J Am Soc Nephrol 2008; 19: 667-671.
18. Cooper GM, Shendure J. Needles in stacks of needles: finding diseasecausal variants in a wealth of genomic data. Nat Rev Genet 2011; 12: 628-640.
19. Pollard KS, Hubisz MJ, Rosenbloom KR et al. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res 2010; 20: 110-121.
20. Cooper GM, Goode DL, Ng SB et al. Single-nucleotide evolutionary constraint scores highlight disease-causing mutations. Nat Methods 2010; 7: 250-251.
21. Cooper GM, Stone EA, Asimenos G et al. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res 2005; 15: 901-913. (Pubitemid 40994210)
22. Goode DL, Cooper GM, Schmutz J et al. Evolutionary constraint facilitates interpretation of genetic variation in resequenced human genomes. Genome Res 2010; 20: 301-310.
23. Adzhubei IA, Schmidt S, Peshkin L et al. A method and server for predicting damaging missense mutations. Nature methods 2010; 7: 248-249.
24. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding nonsynonymous variants on protein function using the SIFT algorithm. Nat Protocols 2009; 4: 1073-1081.
25. Long H, Sabatier C, Ma L et al. Conserved roles for Slit and Robo proteins in midline commissural axon guidance. Neuron 2004; 42: 213-223. (Pubitemid 38501645)
26. Chatterjee R, Ramos E, Hoffman M et al. Traditional and targeted exome sequencing reveals common, rare and novel functional deleterious variants in RET-signaling complex in a cohort of living US patients with urinary tract malformations. Human Genet 2012; 131: 1725-1738.
27. McLaren W, Pritchard B, Rios D et al. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 2010; 26: 2069-2070.